Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8674469 | Nutrition, Metabolism and Cardiovascular Diseases | 2018 | 30 Pages |
Abstract
In Italy, the use of SAP with automated insulin suspension is associated with projected improvements in outcomes as compared to CSII. These benefits translate into an ICER usually considered as good value for money, particularly in patients at elevated risk of hypoglycemia.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A. Nicolucci, M.C. Rossi, D. D'Ostilio, A. Delbaere, S. de Portu, S. Roze,